PMC:7283670 / 64556-64832 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T372","span":{"begin":94,"end":102},"obj":"Disease"},{"id":"T373","span":{"begin":104,"end":113},"obj":"Disease"},{"id":"T374","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A372","pred":"mondo_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A373","pred":"mondo_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A374","pred":"mondo_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T589","span":{"begin":175,"end":177},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T172","span":{"begin":27,"end":38},"obj":"Chemical"},{"id":"T173","span":{"begin":46,"end":54},"obj":"Chemical"},{"id":"T174","span":{"begin":121,"end":132},"obj":"Chemical"},{"id":"T175","span":{"begin":152,"end":163},"obj":"Chemical"},{"id":"T176","span":{"begin":234,"end":239},"obj":"Chemical"}],"attributes":[{"id":"A172","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A173","pred":"chebi_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A174","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A175","pred":"chebi_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A176","pred":"chebi_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}

{"project":"LitCovid-sentences","denotations":[{"id":"T646","span":{"begin":0,"end":276},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T224","span":{"begin":104,"end":113},"obj":"Phenotype"}],"attributes":[{"id":"A224","pred":"hp_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1900","span":{"begin":77,"end":92},"obj":"Species"},{"id":"2133","span":{"begin":94,"end":102},"obj":"Disease"},{"id":"2134","span":{"begin":104,"end":113},"obj":"Disease"},{"id":"2135","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1900","pred":"tao:has_database_id","subj":"1900","obj":"Tax:2697049"},{"id":"A2133","pred":"tao:has_database_id","subj":"2133","obj":"MESH:C000657245"},{"id":"A2134","pred":"tao:has_database_id","subj":"2134","obj":"MESH:D011014"},{"id":"A2135","pred":"tao:has_database_id","subj":"2135","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The efficacy and safety of thalidomide in the adjuvant treatment of moderate new coronavirus (COVID‐19) pneumonia Drug: thalidomide, placebo COVID‐19 thalidomide 100, all, 18 years and older Treatment Placebo comparator: control group: placebo 100 mg, po, qn, for 14 days"}